Skip to main content
An official website of the United States government
Email

Funding for Global Cancer Research and Training

The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.

Sort the table below for current funding opportunities for global cancer research and research training.

Learn more about grants and funding from the National Institutes of Health.

Subscribe for email updates from CGH.

Current Funding Opportunities

Title Announcement Number Opening Date Due Date Additional Resources
Notice of Special Interest (NOSI): Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute  NOT-CA-24-098 09/10/2024 10/12/2024  
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional) RFA-CA-25-012

08/15/2024

12/10/2024

Pre-Application Webinar:
Wednesday, September 25
1:00 - 2:00 PM ET 

Register 

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional) RFA-CA-25-011 08/15/2024 12/10/2024

Pre-Application Webinar:
Wednesday, September 25
1:00 - 2:00 PM ET 

Register 

NCI Small Business Innovation Research (SBIR) Contract Solicitation PHS 2025-1 08/02/2024 10/18/2024 The Center for Global Health seeks proposals related to Topic 474 - Point of Care Technologies for GI Cancer Prevention and Early Detection 
Administrative Supplements to Support Cancer Disparity Collaborative Research Program (Clinical Trial Option) PAR-22-114 12/23/2024 01/23/2025 Administrative Supplements to Support Cancer Disparity Collaborative Research - Fact Sheet
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments NOT-CA-24-064 07/18/2024 10/05/2024 Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health NOFOs:

Reissue of NOT-CA-22-038

Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable NOT-OD-24-038  12/08/2023 01/25/2024 Interested applicants with a proposal focused on research in low- and middle-income countries should contact Paul Pearlman (paul.pearlman@nih.gov) to discuss how to respond to this NOSI.
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) PAR-23-318 02/22/2023 03/21/2025 Letter of Intent Due Date:
February 21, 2025
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 7/27/2023 10/17/2024

This NOSI applies to application due dates on or after October 17, 2023, and subsequent receipt dates through November 18, 2025.

Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-23-056 01/16/2023 10/16/2024  
Co-infection and Cancer (R01 Clinical Trial Not Allowed) PAR-23-055 01/05/2023 10/05/2024  
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-22-085 05/05/2022 10/05/2024 Reissue of PAR-19-193
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-22-086 05/16/2022 10/16/2024 Reissue of PAR-19-194
Notice of Special Interest: Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program NOT-OD-24-040 12/14/2023 02/05/2024

This notice applies to due dates on or after February 5, 2024, and subsequent receipt dates through January 8, 2025.

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-22-105 05/15/2022 10/05/2024  
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-22-106 05/16/2022 10/16/2024  
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-22-109 05/16/2022 10/16/2024  

Training Opportunities

Explore cancer research programs and research training offered and funded through CGH.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Funding for Global Cancer Research and Training was originally published by the National Cancer Institute.”

Email